Real world use of ixekizumab is associated with reductions in concomitant medications among biologic-experienced or biologic-naive patients with psoriasis

被引：0
|
作者：
Wu, Jashin J. [1 ]
Zhu, Baojin [2 ]
Burge, Russel [2 ]
Goldblum, Orin [2 ]
Choong, Casey [2 ]
Edson-Heredia, Emily [2 ]
Amato, David [2 ]
机构：
[1] Dermatol Res & Educ Fdn, Irvine, CA USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
9884
引用
收藏
页码：AB114 / AB114
页数：1
相关论文
共 50 条
  • [1] Real-World Use of Secukinumab Among Biologic-NaiVe and Biologic-Experienced Patients with Ankylosing Spondylitis in the United States
    Oelke, Kurt R.
    Garg, Rahul
    Li, Yunfeng
    Liu, Xing
    Zhou, Huanxue
    Park, Yujin
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] Health care utilization and cost implications of biologic treatment patterns among biologic-naive and biologic-experienced patients with moderate to severe psoriasis
    Feidman, Steven
    Palmer, Jacqueline
    Wang, Xinyue
    Tian, Haijun
    Wei, Zhongyuan
    Djatche, Laurence
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB151 - AB151
  • [3] ANALYSIS EFFICACY OF ABATACEPT TREATMENT IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS.
    Borisova, M.
    Lukina, G.
    Yakov, S.
    Luchikhina, E.
    Karateev, D.
    Novikov, A.
    Aleksandrova, E.
    Aronova, E.
    Glukhova, S.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1300 - 1300
  • [4] Efficacy and safety of bimekizumab in real-world psoriasis management: data from patients who are biologic-naive vs. biologic-experienced
    Megna, Matteo
    Ruggiero, Angelo
    Torta, Ginevra
    Martora, Fabrizio
    Bianco, Mariateresa
    Potestio, Luca
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (10) : 1186 - 1189
  • [5] TWELVE-MONTH FOLLOW UP OF IXEKIZUMAB IN THE BADBIR REGISTRY: BASELINE DEMOGRAPHICS, DRUG SURVIVAL AND EFFECTIVENESS IN BIOLOGIC-NAIVE VERSUS BIOLOGIC-EXPERIENCED PATIENTS WITH PSORIASIS
    Zaheri, S.
    Hughes, J.
    McKenzie, R.
    von Arx, L. B.
    VALUE IN HEALTH, 2022, 25 (01) : S246 - S246
  • [6] Starting-dose trends over time in biologic-naive and biologic-experienced psoriasis patients initiated on ustekinumab or adalimumab
    Guerin, Annie
    Sundaram, Murali
    Gauthier, Genevieve
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB253 - AB253
  • [7] Response and radiographic progression in biologic-naive and biologic-experienced patients with rheumatoid arthritis treated with sirukumab
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 23 - 24
  • [8] RESPONSE AND RADIOGRAPHIC PROGRESSION IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SIRUKUMAB
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 723 - 723
  • [9] Efficacy in biologic-naive and biologic-experienced patients for ixekizumab versus guselkumab in moderate-to-severe psoriasis: head-to-head results from IXORA-R
    Leonardi, Craig
    Bagel, Jerry
    ElMaraghy, Hany
    Renda, Lisa
    Wang, Yan
    Park, So Young
    Burge, Russel
    Janos, Boris
    Maari, Catherine
    Truong, David
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 74 - 74
  • [10] REAL-WORLD EXPERIENCE WITH AN IL-17A BLOCKER IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED RADIOGRAPHIC AND NON-RADIOGRAPHIC AXSPA PATIENTS
    Booth, Nicola
    Hill, Julie
    Leage, Soyi Liu
    Sapin, Christophe
    Holdsworth, Elizabeth
    Antonelli, Silvia
    RHEUMATOLOGY, 2020, 59 : 128 - 128
12345